SewaSLeghaMD

PubMed

• 1 citations
  Differences in nativity, age and gender may impact health behavior and perspectives among Asian Indians.
  Sohini Dhar, Beverly J. Gor, Deborah Banerjee, Sunil Krishnan, V. K. Dorai, Lovell A. Jones, Kanchan Kabad, Lakshmi Rai Naik, Sewa S. Legha, Mala Pande> ;Ethnicity & Health. 2019 Jul 4
• Treating metastatic melanoma: further considerations.
  Sewa S. Legha> ;Oncology. 2009 May 1
• 29 citations
  A randomized phase III trial of biochemotherapy versus interferon-α-2b for adjuvant therapy in patients at high risk for melanoma recurrence
  Kevin B. Kim, S. S. Legha, Rene Gonzalez, Clay M. Anderson, Marcella M. Johnson, Ping Liu, Nicholas E. Papadopoulos, Omar Eton, Carl Plager, Antonio C. Buzaid, Victor ...> ;Melanoma Research. 2009 Feb 1
• A phase III randomized trial of adjuvant biochemotherapy (BC) versus interferon-α-2b (IFN) in patients (pts) with high risk for melanoma recurrence.
  Kim KB, Legha SS, Gonzalez R, Anderson C, Papadopoulos NE, Eton O, Plager C, Roe A, Liu P, Bedikian AY> ;J. Clin. Oncol.. 2006-06-20
• Long-term clinical results of the combination of cisplatin (C), vinblastine (V), DTIC (D) and interferon-alfa (I) with or without tamoxifen (T) for metastatic melanoma.
  Sanguino AM, Bedikian AY, Legha SS, Detry MA, Papadopoulos NE, Hwu P, Hwu W, Kim KB> ;J. Clin. Oncol.. 2006-06-20
• 9 citations
  A phase II open-label trial of apomine (SR-45023A) in patients with refractory melanoma
  Karl D. Lewis, John A. Thompson, Jeffrey S. Weber, William A. Robinson, Steven J. O'Day, Jose Lutzky, Sewa S. Legha, Simon Floret, Francis Ruvuna, Rene Gonzalez> ;Investigational New Drugs. 2006 Jan 13
• 4 citations
  Treatment of brain metastases from melanoma.
  S. S. Legha> ;Journal of Clinical Oncology. 2005 May 1
• 25 citations
  Phase II study of thalidomide in patients with metastatic melanoma.
  Wojciech Z Pawlak, S. S. Legha> ;Melanoma Research. 2004 Feb 1
• 30 citations
  Phase I trial of subcutaneous recombinant human interleukin-2 in patients with metastatic melanoma.
  Omar Eton, Michael G. Rosenblum, S. S. Legha, Wehei Zhang, R N Mary Jo East, Agop Bedikian, Nicholas Papadopoulos, Antonio Buzaid, Robert S. Benjamin> ;Cancer. 2002 Jul 1
• 431 citations
  Phase I and Pharmacokinetic Study of ABI-007, a Cremophor-free, Protein-stabilized, Nanoparticle Formulation of Paclitaxel
  Nuhad K. Ibrahim, Neil Desai, Sewa S. Legha, Patrick Soon-Shiong, Richard L. Theriault, Edgardo Rivera, Bita Esmaeli, Sigrid Ring, Agop Y. Bedikian, Gabriel N. Hortoba...> ;Clinical Cancer Research. 2002 May 1
• 271 citations
  Sequential Biochemotherapy Versus Chemotherapy for Metastatic Melanoma: Results From a Phase III Randomized Trial
  Omar Eton, Sewa S. Legha, Agop Y. Bedikian, J. Jack Lee, Antonio C. Buzaid, Cynthia Hodges, Sigrid Ring, Nicholas E. Papadopoulos, Carl Plager, Mary Jo East, Feng Zhan...> ;Journal of Clinical Oncology. 2002 Apr 15
• A phase II study of "decrescendo" interleukin-2 plus interferon-alpha-2a in patients with progressive metastatic melanoma after chemotherapy.
  Eton O, Buzaid AC, Bedikian AY, Smith TM, Papadopoulos NE, Ellerhorst JA, Hibberts JL, Legha SS, Benjamin RS> ;Cancer. 2000-04-01
• Pilot study of intra-arterial cisplatin and intravenous vinblastine and dacarbazine in patients with melanoma in-transit metastases.
  Eton O, East M, Legha SS, Bedikian A, Buzaid AC, Papadopoulos N, Hodges C, Gianan M, Carrasco CH, Benjamin RS> ;Melanoma Res.. 1999-10-01
• 16 citations
  Phase II trial of escalated dose of tirapazamine combined with cisplatin in advanced malignant melanoma.
  Agop Y. Bedikian, S. S. Legha, Omar Eton, Antonio C. Buzaid, Nicholas E. Papadopoulos, Carl Plager, Susan McIntyre, Viallet J> ;Anti-Cancer Drugs. 1999 Sep 1
• 37 citations
  Phase II trial of doxil for patients with metastatic melanoma refractory to frontline therapy.
  Julie A. Ellerhorst, Agop Y. Bedikian, Sigrid Ring, Antonio C. Buzaid, Omar Eton, Sewa S. Legha> ;Oncology Reports. 1999 Sep 1
• 44 citations
  Acute tumor lysis syndrome associated with concurrent biochemotherapy of metastatic melanoma: a case report and review of the literature.
  Michael P. Castro, Jean VanAuken, Patricia Spencer-Cisek, Sewa S. Legha, Robert W. Sponzo> ;Cancer. 1999 Mar 1
• 22 citations
  Enhancement of cell-mediated immunity in melanoma patients immunized with murine anti-idiotypic monoclonal antibodies (MELIMMUNE) that mimic the high molecular weight ...
  Michael W. Pride, Steve Shuey, Antonio J. Grillo-Lopez, Braslawsky Gary R, Merrick I. Ross, Sewa S. Legha, Omar Eton, Antonio C. Buzaid, C. G. Ioannides, James L. Murray> ;Clinical Cancer Research. 1998 Oct 1
• 154 citations
  Results of interleukin-2-based treatment in advanced melanoma: a case record-based analysis of 631 patients.
  Ulrich Keilholz, Christian Conradt, Sewa S. Legha, David Khayat, Carmen Scheibenbogen, Nick Thatcher, S.H. Goey, Martin Gore, Thierry Dorval, Barry W. Hancock, Corneli...> ;Journal of Clinical Oncology. 1998 Sep 1
• 217 citations
  Development of a biochemotherapy regimen with concurrent administration of cisplatin, vinblastine, dacarbazine, interferon alfa, and interleukin-2 for patients with me...
  Sewa S. Legha, Sigrid Ring, Omar Eton, Agop Y. Bedikian, Antonio C. Buzaid, Carl Plager, Nicholas E. Papadopoulos> ;Journal of Clinical Oncology. 1998 May 1
• 19 citations
  Active immunotherapy with ultraviolet B-irradiated autologous whole melanoma cells plus DETOX in patients with metastatic melanoma.
  Omar Eton, Dmitri D. Kharkevitch, Mary Ann V. Gianan, Merrick I. Ross, Kyogo Itoh, Michael W. Pride, Cherrie K. Donawho, Antonio C. Buzaid, Paul F. Mansfield, Jeffrey ...> ;Clinical Cancer Research. 1998 Mar 1
• 166 citations
  Prognostic factors for survival of patients treated systemically for disseminated melanoma.
  Omar Eton, Sewa S. Legha, Thomas E. Moon, Antonio C. Buzaid, Nicholas E. Papadopoulos, Carl Plager, Andrew Burgess, Agop Y. Bedikian, Sigrid Ring, Qiong Dong, Armand B...> ;Journal of Clinical Oncology. 1998 Mar 1
• 43 citations
  A prospective crossover randomized trial of novobiocin and rifampin prophylaxis for the prevention of intravascular catheter infections in cancer patients treated with...
  Issam I Raad, Ray Y. Hachem, Dima Abi-Said, Kenneth V. I. Rolston, Estella Whimbey, Antonio C. Buzaid, Sewa Legha> ;Cancer. 1998 Jan 15
• 12 citations
  Nitric oxide and neopterin levels and clinical response in stage III melanoma patients receiving concurrent biochemotherapy.
  Clay M. Anderson, A. C. Buzaid, J. Sussman, J. Jack Lee, Francis Ali-Osman, P. G. Braunschweiger, C. Plager, Agop Y. Bedikian, Nicholas E. Papadopoulos, Omar Eton, S. ...> ;Melanoma Research. 1998 Jan 1
• 4 citations
  DNA damage in peripheral blood mononuclear cells correlates with response to biochemotherapy in melanoma.
  Antonio C. Buzaid, Francis Ali-Osman, Akande N, Elizabeth A. Grimm, J. Jack Lee, Agop Y. Bedikian, Omar Eton, Nicholas E. Papadopoulos, Carl Plager, Sewa S. Legha, Rob...> ;Melanoma Research. 1998 Apr 1
• 59 citations
  Phase II study of neoadjuvant concurrent biochemotherapy in melanoma patients with local-regional metastases.
  Antonio C. Buzaid, Maria I. Colome, Agop Y. Bedikian, Omar Eton, Sewa S. Legha, Nicholas E. Papadopoulos, Carl Plager, Merrick I. Ross, Jeffrey E. Lee, Paul F. Mansfie...> ;Melanoma Research. 1998 Dec 1
• Join now to see all